Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

BioCryst Pharmaceuticals Shares Outstanding 2006-2019 | BCRX

BioCryst Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
BioCryst Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 103
2017 84
2016 74
2015 73
2014 67
2013 55
2012 49
2011 45
2010 45
2009 39
2008 38
2007 33
2006 29
2005 26
BioCryst Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 110
Q2 2019 110
Q1 2019 110
Q4 2018 103
Q3 2018 105
Q2 2018 99
Q1 2018 99
Q4 2017 84
Q3 2017 84
Q2 2017 80
Q1 2017 75
Q4 2016 74
Q3 2016 74
Q2 2016 74
Q1 2016 74
Q4 2015 73
Q3 2015 73
Q2 2015 77
Q1 2015 72
Q4 2014 67
Q3 2014 72
Q2 2014 64
Q1 2014 60
Q4 2013 55
Q3 2013 57
Q2 2013 53
Q1 2013 51
Q4 2012 49
Q3 2012 51
Q2 2012 49
Q1 2012 47
Q4 2011 45
Q3 2011 45
Q2 2011 45
Q1 2011 45
Q4 2010 45
Q3 2010 45
Q2 2010 45
Q1 2010 44
Q4 2009 39
Q3 2009 38
Q2 2009 38
Q1 2009 38
Q4 2008 38
Q3 2008 38
Q2 2008 38
Q1 2008 38
Q4 2007 33
Q3 2007 34
Q2 2007 29
Q1 2007 29
Q4 2006 29
Q3 2006 29
Q2 2006 29
Q1 2006 29
Q4 2005 26
Q3 2005 26
Q2 2005 26
Q1 2005 24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.386B $0.021B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.714B 10.07
Zoetis (ZTS) United States $57.208B 34.22
Astellas Pharma (ALPMY) Japan $32.299B 16.13
Eisai (ESALY) Japan $21.618B 41.69
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.387B 20.16
Merck (MKGAF) Germany $14.824B 20.23
Neurocrine Biosciences (NBIX) United States $10.727B 506.43
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $9.077B 18.39
IPSEN SA ADR (IPSEY) France $9.039B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.378B 10.70
Catalent (CTLT) United States $7.550B 30.71
Arrowhead Pharmaceuticals (ARWR) United States $6.272B 94.97
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.851B 17.44
FibroGen (FGEN) United States $4.113B 120.87
United Therapeutics (UTHR) United States $3.959B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.618B 13.22
Nektar Therapeutics (NKTR) United States $3.494B 0.00
Evotec AG (EVTCY) Germany $3.326B 54.42
Sage Therapeutics (SAGE) United States $3.118B 0.00
PTC Therapeutics (PTCT) United States $3.046B 0.00
Heron Therapeutics (HRTX) United States $2.309B 0.00
Xencor (XNCR) United States $2.303B 70.02
Portola Pharmaceuticals (PTLA) United States $2.206B 0.00
Zogenix (ZGNX) United States $2.017B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.934B 61.65
Pacira Pharmaceuticals (PCRX) United States $1.892B 55.99
Tilray (TLRY) Canada $1.848B 0.00
ChemoCentryx (CCXI) United States $1.802B 0.00
USANA Health Sciences (USNA) United States $1.612B 17.20
Corcept Therapeutics (CORT) United States $1.497B 18.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.414B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.242B 28.37
Theravance Biopharma (TBPH) Cayman Islands $1.191B 0.00
ArQule (ARQL) United States $1.148B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.110B 7.57
Karyopharm Therapeutics (KPTI) United States $1.096B 0.00
Endo (ENDP) Ireland $1.093B 2.01
Spectrum Pharmaceuticals (SPPI) United States $1.073B 0.00
Radius Health (RDUS) United States $1.001B 0.00
Aerie Pharmaceuticals (AERI) United States $0.896B 0.00
Flexion Therapeutics (FLXN) United States $0.725B 0.00
Akebia Therapeutics (AKBA) United States $0.721B 0.00
Collegium Pharmaceutical (COLL) United States $0.680B 0.00
TherapeuticsMD (TXMD) United States $0.648B 0.00
Translate Bio (TBIO) United States $0.583B 0.00
ImmunoGen (IMGN) United States $0.582B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.485B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.485B 58.88
Concordia (CXRXF) Canada $0.473B 0.00
Organogenesis Holdings (ORGO) United States $0.456B 0.00
Harpoon Therapeutics (HARP) United States $0.442B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Molecular Templates (MTEM) United States $0.438B 0.00
Dermira (DERM) United States $0.430B 0.00
Ardelyx (ARDX) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.403B 17.38
Indivior (INVVY) United States $0.390B 1.41
DURECT (DRRX) United States $0.383B 0.00
Recro Pharma (REPH) United States $0.369B 0.00
Siga Technologies (SIGA) United States $0.368B 8.41
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.342B 3.99
OptiNose (OPTN) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.320B 0.00
Rafael Holdings (RFL) United States $0.291B 0.00
GlycoMimetics (GLYC) United States $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.253B 3.38
Matinas Biopharma Holdings (MTNB) United States $0.252B 0.00
KalVista Pharmaceuticals (KALV) United States $0.252B 0.00
Calithera Biosciences (CALA) United States $0.238B 0.00
Xeris Pharmaceuticals (XERS) United States $0.234B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.216B 0.00
Aquestive Therapeutics (AQST) United States $0.209B 0.00
Ocular Therapeutix (OCUL) United States $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 32.60
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Concert Pharmaceuticals (CNCE) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.146B 0.00
IMV INC (IMV) Canada $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.143B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.143B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
CannTrust Holdings (CTST) Canada $0.112B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.085B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
Otonomy (OTIC) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
MediWound (MDWD) Israel $0.074B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
PolarityTE (PTE) United States $0.070B 0.00
Capnia (SLNO) United States $0.069B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Natural Alternatives (NAII) United States $0.057B 14.27
SCYNEXIS (SCYX) United States $0.057B 0.00
Novan (NOVN) United States $0.057B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
AgeX Therapeutics (AGE) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Mast Therapeutics (SVRA) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
IsoRay (ISR) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Shineco (TYHT) China $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00